Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Aug;30(8):973-80.
doi: 10.1007/s10096-011-1182-5. Epub 2011 Jan 31.

Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients

Affiliations

Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients

A Lambiase et al. Eur J Clin Microbiol Infect Dis. 2011 Aug.

Abstract

The aims of this study were to evaluate the frequency of Achromobacter xylosoxidans infection in a cohort of cystic fibrosis patients, to investigate antimicrobial sensitivity, to establish possible clonal likeness among strains, and to address the clinical impact of this infection or colonization on the general outcome of these patients. The study was undertaken between January 2004 and December 2008 on 300 patients receiving care at the Regional Cystic Fibrosis Center of the Naples University "Federico II". Sputum samples were checked for bacterial identification. For DNA fingerprinting, pulsed-field gel electrophoresis (PFGE) was carried out. Fifty-three patients (17.6%) had at least one positive culture for A. xylosoxidans; of these, 6/53 (11.3%) patients were defined as chronically infected and all were co-colonized by Pseudomonas aeruginosa. Of the patients, 18.8% persistently carried multidrug-resistant isolates. Macrorestriction analysis showed the presence of seven major clusters. DNA fingerprinting also showed a genetic relationship among strains isolated from the same patients at different times. The results of DNA fingerprinting indicate evidence of bacterial clonal likeness among the enrolled infected patients. We found no significant differences in the forced expiratory volume in 1 s (FEV(1)) and body mass index (BMI) when comparing the case group of A. xylosoxidans chronically infected patients with the control group of P. aeruginosa chronically infected patients.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
PFGE analysis of representative strains of A. xylosoxidans. The numbers indicate the strains in the study. Molecular size marker (a concatemer ladder of lambda phage DNA) was run in lane ST. Sizes are indicated in kilobases
Fig. 2
Fig. 2
Phylogenetic analysis of digitized PFGE DraI profiles of A. xylosoxidans analyzed in the study. Cluster analysis is based on the percentage of distance index. The numbers indicate the strains in the study and the letters indicate the clusters

References

    1. Burns JL, Emerson J, Stapp JR, Yim DL, Krzewinski J, Louden L, Ramsey BW, Clausen CR. Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin Infect Dis. 1998;27(1):158–163. doi: 10.1086/514631. - DOI - PubMed
    1. Lyczak JB, Cannon CL, Pier GB. Lung infections associated with cystic fibrosis. Clin Microbiol Rev. 2002;15(2):194–222. doi: 10.1128/CMR.15.2.194-222.2002. - DOI - PMC - PubMed
    1. Rajan S, Saiman L. Pulmonary infections in patients with cystic fibrosis. Semin Respir Infect. 2002;17(1):47–56. doi: 10.1053/srin.2002.31690. - DOI - PubMed
    1. Saiman L, Siegel J. Infection control in cystic fibrosis. Clin Microbiol Rev. 2004;17(1):57–71. doi: 10.1128/CMR.17.1.57-71.2004. - DOI - PMC - PubMed
    1. Lambiase A, Raia V, Del Pezzo M, Sepe A, Carnovale V, Rossano F. Microbiology of airway disease in a cohort of patients with cystic fibrosis. BMC Infect Dis. 2006;6:4. doi: 10.1186/1471-2334-6-4. - DOI - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources